Breaking News Instant updates and real-time market news.

MU

Micron

$45.55

-0.25 (-0.55%)

, MXIM

Maxim Integrated

$54.03

0.77 (1.45%)

04:55
01/09/18
01/09
04:55
01/09/18
04:55

JPMorgan to hold a forum

16th Annual Tech Forum at the 2018 International CES will be held in Las Vegas on January 8-9.

MU

Micron

$45.55

-0.25 (-0.55%)

MXIM

Maxim Integrated

$54.03

0.77 (1.45%)

CY

Cypress Semiconductor

$16.80

0.16 (0.96%)

F

Ford

$13.15

-0.05 (-0.38%)

GPRO

GoPro

$6.56

-0.96 (-12.77%)

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 16

    Jan

  • 24

    Jan

  • 25

    Jan

  • 26

    Mar

MU Micron
$45.55

-0.25 (-0.55%)

01/05/18
KEYB
01/05/18
NO CHANGE
KEYB
KeyBanc calls memory checks mixed entering Q1
KeyBanc analyst Weston Twigg says his memory contacts maintain a mixed view on memory pricing this year, with DRAM likely up moderately and NAND down. The analyst continues to expect limited new DRAM supply until later this year, creating a tight supply/demand environment, and "substantial" new NAND capacity coming online in the first half of the year, driving lower pricing. He views DRAM strength as positive for Micron (MU), and NAND softness as a potential negative for Micron, Western Digital (WDC) and Seagate (STX).
12/20/17
RSBL
12/20/17
NO CHANGE
Target $85
RSBL
Buy
Rosenblatt ups Micron price target to Street-high $85
Rosenblatt analyst Hans Mosesmann raised his price target for Micron Technology to $85 from $75 and reiterates a Buy rating on the shares following last night's better than expected results and guidance. The analyst believes "impressive demand and content dynamics" will continue to drive the memory cycle.
12/20/17
NEED
12/20/17
NO CHANGE
Target $76
NEED
Buy
Micron multiple should rise as investors appreciate secular shift, says Needham
Needham analyst Rajvindra Gill noted that Micron is trading well below its historical average P/E multiple of 8-10x, but thinks its multiple should rise as investors come to understand how the company benefits from the secular transition away from PCs and smartphones to high-performance computing applications, which brings with it higher capacity and favorable pricing. Gill maintains a Buy rating and $76 price target on Micron following the company's "record" quarter and guidance.
12/20/17
FBCO
12/20/17
NO CHANGE
Target $60
FBCO
Outperform
Micron price target raised to $60 from $50 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Micron to $60 from $50 after the company reported Q1 results and guided Q2 well above consensus. The analyst reiterates an Outperform rating on the shares.
MXIM Maxim Integrated
$54.03

0.77 (1.45%)

10/20/17
LOOP
10/20/17
NO CHANGE
Target $57
LOOP
Buy
Maxim Integrated price target raised to $57 from $53 at Loop Capital
Loop Capital analyst Betsy Van Hees raised her price target on Maxim Integrated to $57 following Q1 results that saw improved outlook in automotive, consumer, and industrial sectors. Van Hees maintains her Buy rating, expecting additional market share gains in auto, continued consumer diversification, and strong shareholder returns.
10/20/17
RHCO
10/20/17
NO CHANGE
Target $53
RHCO
Hold
Maxim Integrated price target raised to $53 from $48 at SunTrust
SunTrust analyst William Stein raised his price target on Maxim Integrated to $53 following Q3 earnings and guidance that suggested strong demand. Stein maintains a Hold rating however, citing longer term concerns with risks related to handset exposure and a stretched valuation.
12/11/17
DBAB
12/11/17
NO CHANGE
Target $50
DBAB
Buy
Intel price target raised to $50 from $45 at Deutsche Bank
Deutsche Bank analyst Ross Seymore raised his price target for Intel to $50 and keeps a Buy rating on the shares. The analyst expects "secular growth hopes" in the semiconductor space to continue in 2018, but be increasingly offset by slowing sector-wide growth and potential compression in "somewhat elevated" valuations. His top picks in the space are Intel, Inphi (IPHI), Maxim Integrated (MXIM), MaxLinear (MXL) and Microsemi (MSCC).
12/15/17
JPMS
12/15/17
NO CHANGE
JPMS
JPMorgan sees opportunities in Wireless Semiconductors, prefers Qorvo
JPMorgan analyst Bill Peterson believes the recent pullback in Wireless Semiconductor names, specifically Apple-exposed stocks, creates a good opportunity for investors to take long positions. The analyst sees the most upside in Qorvo (QRVO). He believes fears of production cuts and demand weakness are overblown. The December quarter and outlook for the March quarter are tracking to company expectations that have been built on conservative prospects for smartphone demand, Peterson tells investors in a research note.
CY Cypress Semiconductor
$16.80

0.16 (0.96%)

12/05/17
CHLM
12/05/17
NO CHANGE
Target $21
CHLM
Buy
Investors should take advantage of pullback in Cypress shares, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss urges investors to take advantage of the pullback, noting that Cypress Semiconductor's (CY) stock is "too cheap." The analyst points out that Internet of Things business is a standout as new customer Amazon (AMZN) grows. He reiterates a Buy rating and $21 price target on Cypress shares.
12/12/17
SUSQ
12/12/17
INITIATION
Target $20
SUSQ
Positive
Cypress Semiconductor initiated with a Positive at Susquehanna
Target $20.
12/18/17
PIPR
12/18/17
INITIATION
Target $20
PIPR
Overweight
Cypress Semiconductor initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Harsh Kumar started Cypress Semiconductor with an Overweight rating and $20 price target. The company is well positioned in several high growth end markets, including automotive, industrial and high-end consumer, the analyst contends. He sees its current business trends continuing in the near to mid-term.
12/13/17
SUSQ
12/13/17
INITIATION
Target $20
SUSQ
Positive
Cypress Semiconductor initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Cypress Semiconductor with a Positive and $20 price target. Rolland believes new management is focused on driving profitable growth through increased exposure to IoT and Automotive end-markets, while improving mix and profitability within its core markets of MCU and memory. The analyst views valuation as "inexpensive" despite the opportunity for double-digit earnings growth.
F Ford
$13.15

-0.05 (-0.38%)

10/30/17
GSCO
10/30/17
DOWNGRADE
GSCO
Sell
Goldman sees 28% downside in GM, downgrades shares to Sell
Goldman Sachs analyst David Tamberrino downgraded General Motors (GM) to Sell from Neutral saying his price target of $32 offers 28% potential downside. The analyst continues to believe the North America auto cycle has peaked and he remains cautious on the sector. He sees "outsized downside" to shares of GM and expects a negative earnings inflection in 2018. Ford's (F) recently refreshed F-Series leaves GM vulnerable to share loss in 2018, Tamberrino tells investors in a research note. The analyst views Ford shares as more fairly valued. He keeps a Neutral rating on the name while upping his target for the shares to $13 from $10.
12/28/17
MSCO
12/28/17
NO CHANGE
MSCO
January to be busy for Autos and Shared Mobility names, says Morgan Stanley
Morgan Stanley analyst Adam Jonas previewed the January calendar for the Autos and Shared Mobility sector, noting that the Vegas CES takes place in the second week and the Detroit Auto Show occurs in the third week of next month. Judging from last year's shows and press releases in recent weeks, he expects "the vast majority" of prepared presentations will focus on autonomous driving, electric propulsion and new business models as companies seek to encourage recognition and valuation of "Auto 2.0 efforts" in the multiples of their stocks, he tells investors. Automakers covered by the firm include Fiat Chrysler (FCAU), Tesla (TSLA), General Motors (GM), Ferrari (RACE) and Ford (F). Auto suppliers covered include Magna (MGA), Goodyear Tire (GT), Adient (ADNT), Delphi Technologies (DLPH), Visteon (VC), BorgWarner (BWA), Aptiv (APTV) and Tenneco (TEN).
12/21/17
OPCO
12/21/17
NO CHANGE
Target $9
OPCO
Outperform
TeleNav extension with Ford should remove overhang, says Oppenheimer
Craig-Hallum analyst Steven Dyer notes that TeleNav (TNAV) announced preliminary Q2 results and amended its current agreement with Ford (F), which he believes is net/net positive for the P&L and should be a catalyst for shares. The analyst thinks the extension with Ford removes a major overhang on shares as it provides visibility for the next three years. Dyer reiterates an Outperform rating on TeleNav's shares, while lowering his price target on the stock to $9 from $12.
10/31/17
MSCO
10/31/17
NO CHANGE
Target $10
MSCO
Underweight
Ford bull case view raised despite 'significant headwinds' at Morgan Stanley
Morgan Stanley analyst Adam Jonas raised his 2017 EPS estimate for Ford to near the midpoint of the company's guidance following its Q3 report and slightly increased his price target on the stock to $10 from $9. While he keeps an Underweight rating on Ford, stating that the headwinds it faces are significant, he also sees the "scope for an equally significant response" and raised his bull case to $25 from $18 given a sum-of-the-parts analysis under which he values Ford's truck business, including the F-series and others, at nearly $20 per share, Ford Europe, S. America and Asia Pacific at "slightly less than zero" and "Ford Future" at $3B, or 74c per Ford share.
GPRO GoPro
$6.56

-0.96 (-12.77%)

01/08/18
01/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GoPro (GPRO) downgraded to Neutral from Buy at Longbow with analyst Joe Wittine saying his channel checks confirmed the holidays missed the company's plan and late quarter $100 price cuts were not enough to save the quarter. 2. Snap (SNAP) downgraded to Hold from Buy at Jefferies with analyst Brent Thill saying he continues to have optimism around Snap's platform, but believes "fundamental execution needs to be shown" before he can be more positive on the name. 3. Cirrus Logic (CRUS) downgraded to Sector Weight from Overweight at KeyBanc with analyst John Vinh citing his "disappointment" with the current iPhone cycle and the lack of meaningful content gains until 2019. 4. Pandora (P) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benjamin Swinburne noting that the company's core free product has not evolved meaningfully and faces continued innovation by Spotify, Apple (AAPL) and Amazon (AMZN) while also being pressured by free music available on Google's (GOOG) YouTube. 5. GrubHub (GRUB) downgraded to Neutral from Outperform at Wedbush with analyst Aaron Turner saying that while he continues to like the company's market opportunity and competitive positioning, the current peak valuation of shares accurately reflects these positive dynamics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
JPMS
01/08/18
NO CHANGE
Target $9
JPMS
Overweight
GoPro price target lowered to $9 from $13 at JPMorgan
JPMorgan analyst Paul Coster lowered his price target for GoPro shares to $9 citing today's negative preannouncement. The analyst now assumes lower pricing and gross margins through 2019. Offsetting this somewhat is reduced operating expenses from GoPro's restructuring initiatives, Coster tells investors in a research note. He keeps an Overweight rating on the shares. The analyst still believes a return to profitability is probable in 2018. GoPro in morning trading is off the day's lows, but the stock remains down 21% to $5.98.
01/08/18
01/08/18
DOWNGRADE

Neutral
GoPro downgraded ahead of expected negative preannouncement at Longbow
As previously reported, Longbow analyst Joe Wittine downgraded GoPro to Neutral from Buy, predicting the company will issue a negative preannouncement this week in concert with its appearance at the CES event. His channel checks confirmed the holidays missed the company's plan and late quarter $100 price cuts were not enough to save the quarter, Wittine tells investors. He hoped for a stronger-than-typical Q1 sell-in, but that has also become less likely based on channel inventory, added Wittine.
01/08/18
LBOW
01/08/18
DOWNGRADE
LBOW
Neutral
GoPro downgraded to Neutral from Buy at Longbow

TODAY'S FREE FLY STORIES

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

HII

Huntington Ingalls

$242.12

5.24 (2.21%)

17:21
01/19/18
01/19
17:21
01/19/18
17:21
Hot Stocks
Huntington Ingalls awarded $125.2M government contract modification »

Huntington Ingalls Inc. -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 21

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

, GD

General Dynamics

$209.10

1.3 (0.63%)

17:20
01/19/18
01/19
17:20
01/19/18
17:20
Hot Stocks
BAE Systems, General Dynamics awarded $237.6M government contract modification »

BAE Systems (BAESY) San…

BAESY

BAE Systems

$33.30

0.18 (0.54%)

GD

General Dynamics

$209.10

1.3 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SYRS

Syros Pharmaceuticals

$10.80

0.27 (2.56%)

17:17
01/19/18
01/19
17:17
01/19/18
17:17
Syndicate
Breaking Syndicate news story on Syros Pharmaceuticals »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$87.81

0.96 (1.11%)

17:13
01/19/18
01/19
17:13
01/19/18
17:13
Hot Stocks
Wintrust Financial raises its minimum wage to $15 per hour »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TWTR

Twitter

$23.66

-0.38 (-1.58%)

17:07
01/19/18
01/19
17:07
01/19/18
17:07
Hot Stocks
Twitter says has identified more IRA and automated Russia-based accounts »

In a statement on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ITEK

Inotek Pharmaceuticals

17:04
01/19/18
01/19
17:04
01/19/18
17:04
Hot Stocks
Boxer Capital reports 5.3% passive stake in Rocket Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIS

Oil States

$32.80

0.35 (1.08%)

17:03
01/19/18
01/19
17:03
01/19/18
17:03
Syndicate
Breaking Syndicate news story on Oil States »

Oil States files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

, QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

16:43
01/19/18
01/19
16:43
01/19/18
16:43
Hot Stocks
Broadcom receives second request from FTC for proposed Qualcomm deal »

Broadcom (AVGO) announced…

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRNC

tronc

$19.53

0.3 (1.56%)

16:37
01/19/18
01/19
16:37
01/19/18
16:37
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, WSJ says »

Ross Levinsohn, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.